Envoy Medical (COCH) Return on Sales (2022 - 2026)

Envoy Medical has disclosed Return on Sales across 5 years of filings, most recently posting 1.53% for Q1 2026.

• Return on Sales for Q1 2026 came in at 1.53%, down 31.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.03% (down 6.0% YoY), and the FY2025 annual result was 0.99%, down 10.0% from the prior year.
• Return on Sales came in at 1.53% for Q1 2026 at Envoy Medical, down from 0.85% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 1.0% in Q3 2022 to a low of 1.53% in Q1 2026.
• The 5-year median for Return on Sales is 0.83% (2024), against an average of 0.7%.
• Across the five-year window, Return on Sales slumped 142 bps in 2023 and soared 32 bps in 2025, its largest moves.
• Envoy Medical's Return on Sales stood at 0.84% in 2022, then climbed by 16 bps to 0.71% in 2023, then tumbled by 66 bps to 1.17% in 2024, then advanced by 28 bps to 0.85% in 2025, then sank by 79 bps to 1.53% in 2026.
• The last three Return on Sales figures came in at 1.53% (Q1 2026), 0.85% (Q4 2025), and 1.47% (Q3 2025), per Business Quant data.